+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Digestive Remedies in the US

  • ID: 573248
  • Report
  • October 2020
  • Region: United States
  • 30 pages
  • Euromonitor International
When the Food and Drug Administration recalled all ranitidine products in early 2020 over the possible carcinogen NDMA, Zantac, the leading H2 blocker, was effectively taken off the market. Although the official recall was in April, many bricks-and-mortar retailers such as CVS and Walgreens had already taken Zantac and other generic ranitidine products off their shelves in late 2019.

The Digestive Remedies in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Digestive Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
KEY DATA FINDINGS

2020 IMPACT
  • Ranitidine recall boosts the sales of famotidine products
  • Travel restrictions throw motion sickness remedies sales into reverse
  • Stress and unhealthy eating continue to drive sales of antacids and laxatives
RECOVERY AND OPPORTUNITIES
  • Recovery in motion sickness remedies will coincide with the travel industry's
  • Private label expected to increase its sales share
  • Digestive enzymes continue to face challenges due to dairy alternative products
CATEGORY DATA
  • Table 1 Sales of Digestive Remedies by Category: Value 2015-2020
  • Table 2 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
  • Table 3 NBO Company Shares of Digestive Remedies: % Value 2016-2020
  • Table 4 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
  • Table 5 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
  • Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
  • COVID-19 impact on consumer health
  • COVID-19 country impact
  • Company response
  • Retailing shift
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
  • Table 8 Life Expectancy at Birth 2015-2020
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2015-2020
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
  • Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
  • Table 14 Distribution of Consumer Health by Format: % Value 2015-2020
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2020
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2020-2025
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
  • Summary 1 OTC: Switches 2019-2020
GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES
  • Summary 2 Research Sources
Note: Product cover images may vary from those shown
Adroll
adroll